Hyperfine (NASDAQ:HYPR – Get Free Report) and Fc Global Realty (OTCMKTS:FCRE – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, risk, analyst recommendations, profitability, dividends, valuation and earnings. Analyst Recommendations This is a summary of […]
Hyperfine (NASDAQ:HYPR – Get Free Report) and CONMED (NYSE:CNMD – Get Free Report) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their earnings, valuation, risk, institutional ownership, dividends, profitability and analyst recommendations. Analyst Ratings This is a summary of recent ratings and […]
Hyperfine (NASDAQ:HYPR – Get Free Report) and Nexalin Technology (NASDAQ:NXL – Get Free Report) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, institutional ownership, risk, earnings, profitability, analyst recommendations and valuation. Analyst Recommendations This is a breakdown of recent […]
Hyperfine (NASDAQ:HYPR – Get Rating) is scheduled to be announcing its earnings results after the market closes on Thursday, May 11th. Analysts expect the company to announce earnings of ($0.16) per share for the quarter. Investors that wish to register for the company’s conference call can do so using this link. Hyperfine Stock Down 3.4 […]
Hyperfine (NASDAQ:HYPR – Get Rating) and Cutera (NASDAQ:CUTR – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, dividends, risk, institutional ownership, valuation, analyst recommendations and earnings. Insider & Institutional Ownership 27.7% of Hyperfine shares are owned by […]